These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8394204)

  • 1. In vitro models of thyroid cancer.
    Wynford-Thomas D
    Cancer Surv; 1993; 16():115-34. PubMed ID: 8394204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro reconstruction of tumour initiation in a human epithelium.
    Bond JA; Wyllie FS; Rowson J; Radulescu A; Wynford-Thomas D
    Oncogene; 1994 Jan; 9(1):281-90. PubMed ID: 8302590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes and thyroid cancer.
    Vecchio G; Santoro M
    Clin Chem Lab Med; 2000 Feb; 38(2):113-6. PubMed ID: 10834397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET.
    Reynolds L; Jones K; Winton DJ; Cranston A; Houghton C; Howard L; Ponder BA; Smith DP
    Oncogene; 2001 Jul; 20(30):3986-94. PubMed ID: 11494127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53-/- mice.
    Powell DJ; Russell JP; Li G; Kuo BA; Fidanza V; Huebner K; Rothstein JL
    Oncogene; 2001 May; 20(25):3235-46. PubMed ID: 11423973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
    Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
    J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiation-induced thyroid cancers].
    Bounacer A; Schlumberger M; Caillou B; Sarasin A; Suárez HG
    Ann Endocrinol (Paris); 2000 May; 61(2):113-8. PubMed ID: 10891661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure.
    Fischer AH; Bond JA; Taysavang P; Battles OE; Wynford-Thomas D
    Am J Pathol; 1998 Nov; 153(5):1443-50. PubMed ID: 9811335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.
    Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G
    Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
    Kimura ET; Nikiforova MN; Zhu Z; Knauf JA; Nikiforov YE; Fagin JA
    Cancer Res; 2003 Apr; 63(7):1454-7. PubMed ID: 12670889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
    Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
    Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro irradiation is able to cause RET oncogene rearrangement.
    Ito T; Seyama T; Iwamoto KS; Hayashi T; Mizuno T; Tsuyama N; Dohi K; Nakamura N; Akiyama M
    Cancer Res; 1993 Jul; 53(13):2940-3. PubMed ID: 8319199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
    Castellone MD; Cirafici AM; De Vita G; De Falco V; Malorni L; Tallini G; Fagin JA; Fusco A; Melillo RM; Santoro M
    Oncogene; 2003 Jan; 22(2):246-55. PubMed ID: 12527893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular endocrinological study of non-neoplastic thyroid diseases and thyroid tumors].
    Mori M; Murakami M
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1209-14. PubMed ID: 9379101
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
    Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
    Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET receptor expression in thyroid follicular epithelial cell-derived tumors.
    Bunone G; Uggeri M; Mondellini P; Pierotti MA; Bongarzone I
    Cancer Res; 2000 Jun; 60(11):2845-9. PubMed ID: 10850426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.